» Articles » PMID: 28367094

LncRNAs: From Basic Research to Medical Application

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2017 Apr 4
PMID 28367094
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

This review aimed to summarize the current research contents about long noncoding RNAs (lncRNAs) and some related lncRNAs as molecular biomarkers or therapy strategies in human cancer and cardiovascular diseases. Following the development of various kinds of sequencing technologies, lncRNAs have become one of the most unknown areas that need to be explored. First, the definition and classification of lncRNAs were constantly amended and supplemented because of their complexity and diversity. Second, several methods and strategies have been developed to study the characteristic of lncRNAs, including new species identifications, subcellular localization, gain or loss of function, molecular interaction, and bioinformatics analysis. Third, based on the present results from basic researches, the working mechanisms of lncRNAs were proved to be different forms of interactions involving DNAs, RNAs, and proteins. Fourth, lncRNA can play different important roles during the embryogenesis and organ differentiations. Finally, because of the tissue-specific expression of lncRNAs, they could be used as biomarkers or therapy targets and effectively applied in different kinds of diseases, such as human cancer and cardiovascular diseases.

Citing Articles

The dysregulation and clinical relevance of lncRNAs MYOSLID and SFTA1P in colorectal cancer patients.

Karamzadeh A, Heidari M, Namazi A, Tabaeian S, Akbari A Mol Biol Rep. 2024; 51(1):1109.

PMID: 39476151 DOI: 10.1007/s11033-024-10020-x.


The Role of Selected lncRNAs in Lipid Metabolism and Cardiovascular Disease Risk.

Gluba-Sagr A, Franczyk B, Rysz-Gorzynska A, Olszewski R, Rysz J Int J Mol Sci. 2024; 25(17).

PMID: 39273193 PMC: 11395304. DOI: 10.3390/ijms25179244.


Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma.

Yao Y, Zhang Q, Wei S, Li H, Zhou T, Zhang Q Transl Cancer Res. 2024; 13(6):2913-2937.

PMID: 38988945 PMC: 11231768. DOI: 10.21037/tcr-23-2243.


Comparative Analysis of mRNA and lncRNA Expression Profiles in Testicular Tissue of Sexually Immature and Sexually Mature Mongolian Horses.

Liu Y, Du M, Zhang L, Wang N, He Q, Cao J Animals (Basel). 2024; 14(12).

PMID: 38929336 PMC: 11200857. DOI: 10.3390/ani14121717.


AMPFLDAP: Adaptive Message Passing and Feature Fusion on Heterogeneous Network for LncRNA-Disease Associations Prediction.

Su Y, Liu J, Wu Q, Gao Z, Wang J, Li H Interdiscip Sci. 2024; 16(3):608-622.

PMID: 38581626 DOI: 10.1007/s12539-024-00610-5.


References
1.
Hou P, Zhao Y, Li Z, Yao R, Ma M, Gao Y . LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis. 2014; 5:e1287. PMC: 4611722. DOI: 10.1038/cddis.2014.249. View

2.
Zhuang W, Ge X, Yang S, Huang M, Zhuang W, Chen P . Upregulation of lncRNA MEG3 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells From Multiple Myeloma Patients By Targeting BMP4 Transcription. Stem Cells. 2015; 33(6):1985-97. DOI: 10.1002/stem.1989. View

3.
Yuan C, Li H, Zhu L, Liu Z, Zhou J, Shu Y . Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer. Neoplasma. 2016; 63(3):442-9. DOI: 10.4149/314_150825N45. View

4.
Liang W, Fu W, Wong C, Wang Y, Wang W, Hu G . The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 2015; 6(26):22513-25. PMC: 4673179. DOI: 10.18632/oncotarget.4154. View

5.
Yang J, Li J, Shao P, Zhou H, Chen Y, Qu L . starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res. 2010; 39(Database issue):D202-9. PMC: 3013664. DOI: 10.1093/nar/gkq1056. View